Epilepsy Currents
Scope & Guideline
Elevating research, enriching lives affected by epilepsy.
Introduction
Aims and Scopes
- Clinical Management of Epilepsy:
Focuses on the best practices for managing epilepsy in clinical settings, including surgical interventions, medication management, and patient-centered care. - Neurobiological Mechanisms:
Investigates the underlying biological processes involved in epilepsy, such as neuronal excitability, genetic factors, and neuroinflammation. - Innovative Therapeutics:
Explores new treatment modalities, including pharmacological advancements, neuromodulation techniques, and gene therapies aimed at improving patient outcomes. - Epidemiology and Public Health:
Studies the epidemiological aspects of epilepsy, including prevalence, health disparities, and the impact of social factors on epilepsy care. - Technology and Epilepsy:
Examines the role of technology in epilepsy diagnosis and management, including telemedicine, wearable devices, and artificial intelligence applications.
Trending and Emerging
- Telemedicine and Remote Monitoring:
The use of telehealth in epilepsy care is increasingly recognized for improving access and equity in treatment, especially in underserved communities. - Machine Learning and AI Applications:
Emerging applications of artificial intelligence and machine learning for predicting seizure occurrences and optimizing treatment protocols are becoming a significant focus. - Health Equity and Social Determinants:
Research addressing health disparities and the social determinants of epilepsy care is gaining importance, highlighting the need for equitable access to treatment. - Neuroinflammation and Epilepsy:
There is growing interest in understanding the role of neuroinflammation in epilepsy pathophysiology and its potential as a therapeutic target. - Personalized Medicine in Epilepsy:
The trend towards personalized approaches in epilepsy treatment, including genetic testing and tailored therapies, is becoming increasingly prominent.
Declining or Waning
- Traditional Pharmacotherapy:
The focus on older antiseizure medications is decreasing as newer treatments and personalized medicine approaches gain prominence. - Generalized Epilepsy Research:
There has been a noticeable decline in studies specifically targeting generalized epilepsies, as research shifts towards more complex and specific forms of epilepsy. - Basic Science Studies:
While foundational research remains important, there is a waning emphasis on basic science studies in favor of translational and clinical applications. - Single-Center Studies:
The prevalence of studies conducted at single institutions is declining, with a trend towards multi-center collaborations to enhance the robustness of findings. - Animal Models in Epilepsy Research:
Although still relevant, the reliance on animal models for epilepsy research is decreasing as researchers seek more immediate clinical applications and human-focused studies.
Similar Journals
Neurochirurgie
Elevating Neurological Research to New HeightsNeurochirurgie, published by MASSON EDITEUR, stands as a prominent peer-reviewed journal in the fields of neurology and surgery, reflecting its commitment to advancing clinical practices and surgical innovations. With an impressive history dating back to 1955 and a convergence period extending to 2024, this journal serves a vital role in disseminating comprehensive research and updates relevant to both medical practitioners and researchers. Neurochirurgie holds a respectable Q3 ranking in clinical neurology and a Q2 ranking in surgery as of 2023, positioning it within the upper echelons of medical journals; its Scopus rankings further underline its growing influence, particularly in the surgical domain. Despite its non-open access model, the journal offers a platform where high-quality, rigorously vetted studies can be accessed, fostering an environment of knowledge exchange that is essential for the ongoing development of neurosurgical practices. For researchers, professionals, and students alike, Neurochirurgie presents an invaluable resource for staying at the forefront of neurological research and surgical advancements.
Annals of Indian Academy of Neurology
Exploring Innovations in Neurological ResearchAnnals of Indian Academy of Neurology is a premier open access journal dedicated to advancing the field of Neurology, serving as a vital resource for researchers, healthcare professionals, and students since its inception in 2006. Published by the esteemed Wolters Kluwer Medknow Publications, this journal has established itself within the academic community, boasting a Q3 quartile ranking in clinical neurology according to the 2023 category quartiles and a Scopus rank placing it in the 35th percentile among 400 comparable journals. With a focus on clinical advancements and research innovations in neurology, the journal aims to disseminate high-quality and impactful studies that address the complex challenges faced in the neurological landscape, particularly within the Indian context. The open access model ensures that the latest research is readily accessible to a global audience, thereby promoting collaboration and knowledge sharing within the neurosciences.
Archives of Neuroscience
Empowering the neuroscience community with open access knowledge.Archives of Neuroscience is a multidisciplinary journal dedicated to advancing the field of neuroscience through the publication of original research articles, review papers, and case studies. Published by BRIEFLAND, this journal aims to bridge the gap between neuroscience research and clinical applications, fostering a deeper understanding of brain function, neurological disorders, and potential therapeutic approaches. With an ISSN of 2322-3944 and an E-ISSN of 2322-5769, Archives of Neuroscience serves as an essential platform for researchers, professionals, and students alike, encouraging open access to knowledge and insights that drive innovation in the field. Although coverage was discontinued in Scopus from 2016 to 2017, the journal continues to uphold rigorous standards of academic excellence, making it a valuable resource for the neuroscience community seeking to explore and disseminate new findings. The journal is committed to providing timely access to research tools and findings that are crucial for informed decision-making in both academic and clinical settings.
Current Problems in Pediatric and Adolescent Health Care
Empowering healthcare professionals with essential insights.Current Problems in Pediatric and Adolescent Health Care is a distinguished peer-reviewed journal published by Elsevier Science Inc, dedicated to advancing the field of pediatric and adolescent health. With an impressive Impact Factor indicative of its relevance—ranking in the 79th percentile in its category and classified in Q2—this journal serves as a vital resource for healthcare professionals, researchers, and students. Covering a wide range of topics from clinical practice to innovative research findings in pediatrics, this scholarly publication is essential for those involved in optimizing health care for children and adolescents. The journal's comprehensive articles and reviews from 1996 to present reflect the evolving landscape of child health, making it a key contributor to evidence-based practice and policy-making in the United States and beyond. While the journal is not open access, readers gain invaluable insights to further their knowledge and improve healthcare outcomes for the younger population.
Archives of Epilepsy
Connecting researchers for transformative epilepsy solutions.Archives of Epilepsy is a pioneering academic journal dedicated to advancing the field of epilepsy research and clinical practice. Published by GALENOS PUBL HOUSE in Turkey, this Open Access journal has embraced the principle of unrestricted access since its inception in 2012, allowing researchers, healthcare professionals, and students from around the world to engage with cutting-edge findings in neuropathology. With a focus on clinical and neuroscience aspects of neurology, the journal occupies a significant position in the academic landscape, currently ranked in the Q4 quartile in both Neurology and Clinical Neurology categories as of 2023. Though it faces challenges in its Scopus rankings with a current percentile of 2nd in Medicine - Neurology (Clinical) and 1st in Neuroscience - Neurology, it offers a valuable platform for emerging studies. The journal's commitment to fostering a comprehensive understanding of epilepsy is crucial, as it facilitates broader discourse on effective treatments and patient care strategies. We invite researchers and practitioners to explore the impactful articles published in the Archives of Epilepsy and contribute to an evolving dialogue that strives to improve outcomes for individuals affected by epilepsy.
Journal of Clinical Neurology
Innovative Insights into Clinical NeurologyThe Journal of Clinical Neurology, published by the Korean Neurological Association, is a prominent open-access journal that has been disseminating crucial findings in the field of neurology since its inception in 2008. With an ISSN of 1738-6586 and an E-ISSN of 2005-5013, this journal provides a vital platform for researchers and clinicians to share innovative research, reviews, and case studies that advance understanding and treatment of neurological disorders. The journal has established its reputation, achieving a Q3 ranking in Neurology and a Q2 ranking in Clinical Neurology in 2023, placing it among the noteworthy sources in the medical community. With its open-access format since 2011, it facilitates broad dissemination of knowledge to both the scientific community and the public, supporting the journal's mission to enhance clinical practice and promote neurological health in South Korea and beyond. As of October 2023, it holds influential Scopus ranks, reflecting its impact and relevance in the ever-evolving landscape of neuroscience. Researchers, professionals, and students alike are encouraged to contribute to and engage with the ongoing discourse by submitting their work and accessing a wealth of resources through this esteemed publication.
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
Uniting knowledge and innovation in pediatric neurology.European Journal of Paediatric Neurology, published by Elsevier Science Ltd, is a premier academic journal dedicated to advancing the field of paediatric neurology. With its ISSN 1090-3798 and E-ISSN 1532-2130, this journal serves as a vital resource for researchers, clinicians, and students alike, focusing on the latest findings and innovative treatments in paediatric neurological disorders. The journal has established itself as a leading publication in its field, achieving a Q1 classification in Pediatrics, Perinatology and Child Health, and holding a reputable Q2 status in Clinical Neurology as of 2023. Positioned within the top 88th percentile in Pediatrics and the 76th percentile in Clinical Neurology according to Scopus ranks, it publishes rigorous peer-reviewed articles that contribute significantly to clinical practice and research. Although not open access, the journal provides vital insights into the complexities of neurological conditions affecting the pediatric population, making it an essential tool for scholars and professionals striving to improve child health outcomes. With a publication trajectory spanning from 1997 to 2024, it continues to be at the forefront of paediatric neurological research, inspiring innovation and collaboration in the scientific community.
Journal of Central Nervous System Disease
Transforming research into solutions for CNS diseases.Welcome to the Journal of Central Nervous System Disease, a premier Open Access publication dedicated to advancing the understanding of neurological disorders and their underlying mechanisms. Published by SAGE Publications Ltd, this esteemed journal has been serving the scientific community since 2009 and is committed to disseminating high-quality research that spans from clinical neurology to cellular and molecular neuroscience. With an impressive impact factor, the journal ranks within the top quartiles—Q2 in both Neurology and Clinical Neurology, and Q3 in Cellular and Molecular Neuroscience as of 2023. The journal's indexing in Scopus reflects its significant contribution to the field, being ranked #83 out of 400 in clinical neurology and #38 out of 97 in cellular and molecular neuroscience. This essential resource, based in the United States, is crucial for researchers, clinicians, and students looking to stay at the forefront of neurological science. By providing Open Access options, we ensure that groundbreaking research is readily available to a global audience, fostering collaboration and innovation in the study of central nervous system diseases.
EPILEPTIC DISORDERS
Connecting Researchers and Clinicians in EpilepsyEpileptic Disorders is a leading journal dedicated to the field of epilepsy research and its clinical implications, published by Wiley. With its ISSN 1294-9361 and E-ISSN 1950-6945, the journal has established a significant presence in the medical and neurological communities, reflecting its commitment to advancing knowledge in the study of epilepsy and related disorders. Covering a broad spectrum of topics, Epileptic Disorders aims to provide a platform for researchers and clinicians to share cutting-edge research findings, clinical insights, and innovative treatments, maintaining a robust presence in Q2 quartiles across multiple categories including Medicine (miscellaneous) and Neurology. The journal, which has been in continuous publication since 1999, also ranks within the 51st and 47th percentiles in the Scopus rankings for Medicine and Neuroscience, respectively, underscoring its relevance and impact in the field. Although not an open-access publication, Epileptic Disorders remains a crucial resource for those seeking to deepen their understanding of epilepsy and improve patient care through research.
JAMA Neurology
Pioneering Research in the Realm of NeurologyJAMA Neurology is a leading peer-reviewed journal published by the American Medical Association, focused on advancing the understanding and treatment of neurological disorders. With an impressive impact factor and ranked in the 99th percentile among clinical neurology journals, this publication is recognized as Q1 in its category for 2023, highlighting its significance in the field. Since its inception, the journal has provided a platform for high-quality research, clinical trials, and reviews that inform both clinicians and researchers. Operating from its headquarters in Chicago, Illinois, JAMA Neurology offers rich insights into the latest advancements in neurology, featuring articles that span a wide range of topics including neurodegenerative diseases, stroke, epilepsy, and neurocritical care. Researchers and professionals are encouraged to access the journal’s content freely, as it employs open access options to promote the dissemination of critical knowledge. As a critical resource in the field of neurology, JAMA Neurology is essential for anyone involved in this dynamic and rapidly evolving specialty.